Accidental drug overdoses, including those involving opioids, are a leading cause of accidental deaths in America.
- In 2016, opioid overdoses claimed over 42,000 lives, more than any year on record.
- 40% of all opioid overdose deaths involve a prescription opioid.
- Each day, more than 1,000 people are treated in the Emergency Department for misusing prescription opioids.
- Americans consume more opioids than any other Country.
According to Nora D. Volkow, Director of the National Institute of Drug Abuse (NIDA), accidental opioid overdose is a “public health epidemic with devastating consequences.”
The Human Cost
This epidemic affects all layers of American society, without regard to geography, age, race, or socioeconomic status. By 2013, unintentional drug poisoning was the leading cause of accidental death in the United States. The consequences are not only national, but also deeply personal: deaths from accidental opioid overdose send out tidal waves of pain through families and friends, leaving a deep and enduring sense of loss.
Because accidental overdose is such a far-ranging public health problem, it’s important that everyone from parents to providers to policymakers work together to save lives. Fortunately, there is a growing chorus of voices that recognize the seriousness of this problem and are calling for measures to address this epidemic. On the federal, state, local, and advocacy levels, key stakeholders have been developing policies and practices to help prevent accidental opioid-related overdoses and deaths.
NARCAN® Nasal Spray was developed in collaboration with the National Institute on Drug Abuse (NIDA) to address the public health issue of accidental overdose fatalities in America. It was approved in November of 2015 under the US Food and Drug Administration’s (FDA) Fast Track Designation and Priority Review process. It is the goal of ADAPT Pharma® to expand affordable access to NARCAN® Nasal Spray while progressing our pipeline of opioid overdose and addiction treatments.